Krsnaa Diagnostics: It offers diagnostic services such as imaging and radiology servicesKrsnaa Diagnostics' Rs 1200 crore initial public offering (IPO) will open for bidding on August 4.
The IPO, which will close on August 6, will include a fresh problem of shares worth Rs 400 crore and a sell (OFS) of approximately 94,16,377 shares by existing shareholders, consisting of Phi Capital, Kitara, Somerset Indus Health Care Fund I and Lotus Management Solutions.
The shares of the Pune-based diagnostics chain are most likely to be noted on the BSE and NSE on August 17.
An overall of 75 percent of the problem has actually been reserved for qualified institutional purchasers (QIB), 15 per cent for non-institutional investors and 10 per cent for retail financiers, the diagnostic companies said in its red herring prospectus.Krsnaa Diagnostics will utilize the earnings from the share sale to establish diagnostics centres at Punjab, Karnataka, Himachal Pradesh and Maharashtra, repay existing loans and for basic business purposes.Krsnaa Diagnostics was integrated in the year 2010.
It supplies a wide range of diagnostic services such as imaging and radiology services, medical lab tests, pathology and tele-radiology services to personal and public health centers, medical colleges and neighborhood health centres.
As of December 31, 2020, it operated 1,801 diagnostic centres across 13 cities in the country.Rajendra Mutha is the promoter of Krsnaa Diagnostics.DAM Capital Advisors (Previously IDFC Securities), Equirus Capital, IIFL Holdings and JM Monetary Consultants are the lead managers to the public problem of Krsnaa Diagnostics, whereas KFintech is the registrar to the problem.